• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示默林的魔法奥秘。

Shedding light on Merlin's wizardry.

作者信息

Okada Tomoyo, You Liru, Giancotti Filippo G

机构信息

Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Trends Cell Biol. 2007 May;17(5):222-9. doi: 10.1016/j.tcb.2007.03.006. Epub 2007 Apr 17.

DOI:10.1016/j.tcb.2007.03.006
PMID:17442573
Abstract

Inactivation of the tumor suppressor Merlin, encoded by the NF2 (Neurofibromatosis type 2) gene, contributes to malignant conversion in many cell types. Merlin is an Ezrin-Radixin-Moesin protein and localizes underneath the plasma membrane at cell-cell junctions and other actin-rich sites. Recent studies indicate that Merlin mediates contact inhibition of proliferation by blocking recruitment of Rac to the plasma membrane. In mitogen-stimulated cells, p21-activated kinase phosphorylates Ser518 in the C-terminus of Merlin, inactivating the growth suppressive function of the protein. Furthermore, the myosin phosphatase MYPT1-PP1delta, has been identified as a direct activator of Merlin and its inhibition has been linked to malignant transformation. Finally, studies in the fruit fly Drosophila melanogaster have revealed that Merlin functions together with the band 4.1 protein Expanded to promote [corrected] the endocytosis of many signaling receptors, limiting [corrected] their accumulation at the plasma membrane, and to activate [corrected] the Hippo signaling pathway. Here, we review these recent findings and their relevance to the tumor suppressor function of Merlin.

摘要

由NF2(神经纤维瘤病2型)基因编码的肿瘤抑制因子Merlin的失活,在许多细胞类型中促成恶性转化。Merlin是一种埃兹蛋白-根蛋白-膜突蛋白,定位于细胞间连接和其他富含肌动蛋白的位点的质膜下方。最近的研究表明,Merlin通过阻止Rac募集到质膜来介导增殖的接触抑制。在有丝分裂原刺激的细胞中,p21活化激酶使Merlin C末端的Ser518磷酸化,从而使该蛋白的生长抑制功能失活。此外,肌球蛋白磷酸酶MYPT1-PP1δ已被鉴定为Merlin的直接激活剂,其抑制作用与恶性转化有关。最后,对果蝇的研究表明,Merlin与4.1带蛋白Expanded共同发挥作用,促进许多信号受体的内吞作用,限制它们在质膜上的积累,并激活Hippo信号通路。在此,我们综述这些最新发现及其与Merlin肿瘤抑制功能的相关性。

相似文献

1
Shedding light on Merlin's wizardry.揭示默林的魔法奥秘。
Trends Cell Biol. 2007 May;17(5):222-9. doi: 10.1016/j.tcb.2007.03.006. Epub 2007 Apr 17.
2
NF2: the wizardry of merlin.神经纤维瘤病2型:梅林的魔法
Genes Chromosomes Cancer. 2003 Dec;38(4):389-99. doi: 10.1002/gcc.10282.
3
Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.DU145前列腺癌细胞中NF2肿瘤抑制蛋白默林的失活。
Prostate. 2008 Jun 15;68(9):975-84. doi: 10.1002/pros.20760.
4
Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin.神经纤维瘤病2型肿瘤抑制因子默林的细胞周期依赖性核质穿梭
Oncogene. 2005 Feb 10;24(7):1150-8. doi: 10.1038/sj.onc.1208283.
5
Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.人、大鼠和小鼠中枢神经系统中神经纤维瘤病2型蛋白默林和ERM蛋白埃兹蛋白的特性分析
Mol Cell Neurosci. 2005 Apr;28(4):683-93. doi: 10.1016/j.mcn.2004.11.014.
6
Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.恶性间皮瘤细胞中 Merlin 的失活和 Hippo 信号级联的失调。
Pathol Int. 2011 Jun;61(6):331-44. doi: 10.1111/j.1440-1827.2011.02666.x. Epub 2011 May 2.
7
Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.默林/2型神经纤维瘤病通过抑制Ras和Rac的激活来抑制生长。
Cancer Res. 2007 Jan 15;67(2):520-7. doi: 10.1158/0008-5472.CAN-06-1608.
8
Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.默林磷酸化对神经纤维瘤病2(NF2)基因功能的影响。
Oncogene. 2004 Jan 15;23(2):580-7. doi: 10.1038/sj.onc.1207142.
9
Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.蛋白激酶A介导的神经纤维瘤病2型肿瘤抑制蛋白默林丝氨酸10位点的磷酸化作用影响肌动蛋白细胞骨架。
Oncogene. 2008 May 22;27(23):3233-43. doi: 10.1038/sj.onc.1210988. Epub 2007 Dec 10.
10
Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.Akt磷酸化通过泛素化和降解作用调节肿瘤抑制因子默林。
Nat Cell Biol. 2007 Oct;9(10):1199-207. doi: 10.1038/ncb1641. Epub 2007 Sep 23.

引用本文的文献

1
Short‑term efficacy assessment of brigatinib for the treatment of neurofibromatosis type 2: A retrospective study.布吉他滨治疗2型神经纤维瘤病的短期疗效评估:一项回顾性研究。
Oncol Lett. 2025 Apr 11;29(6):287. doi: 10.3892/ol.2025.15033. eCollection 2025 Jun.
2
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.胸膜间皮瘤病理诊断方法中的挑战
Cancers (Basel). 2025 Feb 1;17(3):481. doi: 10.3390/cancers17030481.
3
Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.通过诱导敲除nf2a/b生成斑马鱼神经纤维瘤病模型。
Dis Model Mech. 2024 Dec 1;17(12). doi: 10.1242/dmm.050862. Epub 2024 Dec 4.
4
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.神经纤维瘤病2型:癌症代谢重编程和肿瘤免疫中被低估的因素
NPJ Precis Oncol. 2024 Jun 15;8(1):133. doi: 10.1038/s41698-024-00627-5.
5
Generation of a zebrafish neurofibromatosis model via inducible knockout of .通过诱导敲除……生成斑马鱼神经纤维瘤病模型。 (原文中“of”后面缺少具体内容)
bioRxiv. 2024 Apr 27:2024.04.23.590787. doi: 10.1101/2024.04.23.590787.
6
Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.神经纤维瘤病 2 型相关雪旺细胞瘤病的临床前模型中同时抑制 PI3K 和 PAK。
Oncogene. 2024 Mar;43(13):921-930. doi: 10.1038/s41388-024-02958-w. Epub 2024 Feb 9.
7
mTOR Signaling and Potential Therapeutic Targeting in Meningioma.mTOR 信号通路与脑膜瘤的潜在治疗靶点
Int J Mol Sci. 2022 Feb 10;23(4):1978. doi: 10.3390/ijms23041978.
8
Importance of Cullin4 Ubiquitin Ligase in Malignant Pleural Mesothelioma.Cullin4泛素连接酶在恶性胸膜间皮瘤中的重要性
Cancers (Basel). 2020 Nov 20;12(11):3460. doi: 10.3390/cancers12113460.
9
The multifarious regulation of the apical junctional complex.顶端连接复合体的多样化调节。
Open Biol. 2020 Feb;10(2):190278. doi: 10.1098/rsob.190278. Epub 2020 Feb 19.
10
An update on the CNS manifestations of neurofibromatosis type 2.神经纤维瘤病 2 型的中枢神经系统表现的最新进展。
Acta Neuropathol. 2020 Apr;139(4):643-665. doi: 10.1007/s00401-019-02029-5. Epub 2019 Jun 4.